In recent months, veterinarians have faced a critical shortage of vaccines for cats and dogs, the National Veterinary Chamber ...

Kennedy’s decision to replace ACIP wholesale and the comments he has made about deviating from standard vaccine policymaking ...

Two new Omicron subvariants are gaining ground in the U.S. as some people report experiencing respiratory symptoms like ...

Some vaccines may reduce the risk of dementia through a double effect in which the jabs help protect the brain through their ...

Technological advances in the design and delivery of mRNA have catalysed the rapid development of mRNA COVID-19 vaccines by ...

The FDA has expanded the approval of mResvia to include active immunization in high-risk individuals 18 through 59 years of age.

For the 2025-2026 respiratory viral season, Moderna intends to have mResvia available for both FDA-approved patient populations.

The new COVID-19 variant NB.1.8.1, known as Nimbus, is causing concern due to its subtle symptoms and high transmission rate.

Research shows respiratory viruses like flu and COVID can significantly increase the risk of heart attacks and strokes, ...

Discover how mRNA vaccines could revolutionize medicine by targeting 9 major diseases. Learn about breakthrough treatments ...

An unfortunate and unintentional logo design ultimately led the Chesapeake Baysox to partner for a good cause.

The recent death of a British woman from rabies is a sobering reminder of the risks posed by the fatal disease ...